Busby J, et al. - The association between post-diagnosis angiotensin receptor blocker (ARB) use and gastro-oesophageal cancer survival was determined. In the current study it was shown that cancer-specific mortality was moderately reduced among ARB users in this large population-based gastro-oesophageal cancer cohort.